Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Peptide backbone modification in the bend region of amyloid-β inhibits fibrillogenesis but not oligomer formation

Journal Article · · Journal of Peptide Science
DOI:https://doi.org/10.1002/psc.2879· OSTI ID:1467394
 [1];  [2];  [3]
  1. Univ. of Chicago, IL (United States). Dept. of Biochemistry and Molecular Biology, and Inst. for Biophysical Dynamics; , Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158
  2. Univ. of Chicago, IL (United States). Dept. of Pathology
  3. Univ. of Chicago, IL (United States). Dept. of Biochemistry and Molecular Biology; Univ. of Chicago, IL (United States). Dept. of Pathology

Current evidence suggests that oligomers of the amyloid-β (Aβ) peptide are involved in the cellular toxicity of Alzheimer’s disease, yet their biophysical characterization remains difficult because of lack of experimental control over the aggregation process under relevant physiologic conditions. Here in this paper, we show that modification of the Aβ peptide backbone at Gly29 allows for the formation of oligomers but inhibits fibril formation at physiologic temperature and pH. Our results suggest that the putative bend region in Aβ is important for higher-order aggregate formation.

Research Organization:
Univ. of Chicago, IL (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
FG02-04ER63786
OSTI ID:
1467394
Journal Information:
Journal of Peptide Science, Journal Name: Journal of Peptide Science Journal Issue: 5 Vol. 22; ISSN 1075-2617
Publisher:
Wiley - European Peptide SocietyCopyright Statement
Country of Publication:
United States
Language:
English

References (24)

Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease journal March 1991
Protein misfolding, evolution and disease journal September 1999
Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity journal August 2012
Aβ40-Lactam(D23/K28) Models a Conformation Highly Favorable for Nucleation of Amyloid journal April 2005
Spatial Separation of β-Sheet Domains of β-Amyloid:  Disruption of Each β-Sheet by N -Methyl Amino Acids journal August 2006
Assembly of Aβ Amyloid Protofibrils:  An in Vitro Model for a Possible Early Event in Alzheimer's Disease journal July 1999
Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis journal December 1992
Structural and Spectroscopic Studies of Peptoid Oligomers with α-Chiral Aliphatic Side Chains journal November 2003
Oligo( N- aryl glycines): A New Twist on Structured Peptoids journal December 2008
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation journal August 2001
Synthesis, stability and optimized photolytic cleavage of 4-methoxy-2-nitrobenzyl backbone-protected peptides journal January 2006
3D structure of Alzheimer's amyloid- (1-42) fibrils journal November 2005
Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus journal October 2007
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation journal March 2008
Molecular basis of  -amyloid oligomer recognition with a conformational antibody fragment journal July 2012
A structural model for Alzheimer's  -amyloid fibrils based on experimental constraints from solid state NMR journal December 2002
Amyloid β-Protein Fibrillogenesis: STRUCTURE AND BIOLOGICAL ACTIVITY OF PROTOFIBRILLAR INTERMEDIATES journal September 1999
Inhibition of Toxicity in the β-Amyloid Peptide Fragment β-(25–35) Using N -Methylated Derivatives : A GENERAL STRATEGY TO PREVENT AMYLOID FORMATION journal May 2000
On the nucleation of amyloid β-protein monomer folding journal June 2005
In situ neutralization in Boc-chemistry solid phase peptide synthesis: Rapid, high yield assembly of difficult sequences journal September 1992
Physiochemical characterization of the Alzheimer's disease-related peptides Aβ1-42Arctic and Aβ1-42wt journal June 2006
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics journal July 2002
Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils journal January 2007
Rationally Designed Turn Promoting Mutation in the Amyloid-β Peptide Sequence Stabilizes Oligomers in Solution journal July 2011

Cited By (1)

Factors affecting the physical stability (aggregation) of peptide therapeutics journal October 2017

Similar Records

Amyloid β oligomers induce interleukin-1β production in primary microglia in a cathepsin B- and reactive oxygen species-dependent manner
Journal Article · Fri Mar 13 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22458528

Inhibition of Amyloid β-Induced Lipid Membrane Permeation and Amyloid β Aggregation by K162
Journal Article · Thu Jan 21 23:00:00 EST 2021 · ACS Chemical Neuroscience · OSTI ID:1810820

In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
Journal Article · Tue Sep 15 00:00:00 EDT 2015 · AIP Advances · OSTI ID:22584034